دورية أكاديمية

Identification of the flotillin-1/2 heterocomplex as a target of autoantibodies in bona fide multiple sclerosis

التفاصيل البيبلوغرافية
العنوان: Identification of the flotillin-1/2 heterocomplex as a target of autoantibodies in bona fide multiple sclerosis
المؤلفون: Hahn, S., Trendelenburg, G., Scharf, M., Denno, Y., Brakopp, S., Teegen, B., Probst, C., Wandinger, K. P., Buttmann, M., Haarmann, A., Szabados, F., Dahl, M. vom, Kümpfel, T., Eichhorn, P., Gold, H., Paul, F., Jarius, S., Melzer, N., Stöcker, W., Komorowski, L.
المصدر: Journal of Neuroinflammation
بيانات النشر: Ludwig-Maximilians-Universität München
سنة النشر: 2017
المجموعة: Open Access LMU (Ludwig-Maximilians-University Munich)
مصطلحات موضوعية: Medizin, ddc:610
الوصف: Background: Autoantibodies, in particular those against aquaporin-4 and myelin-oligodendrocyte glycoprotein (MOG), aid as biomarkers in the differential diagnosis of demyelination. Here, we report on discovery of autoantibodies against flotillin in patients with multiple sclerosis (MS). Methods: The target antigen was identified by histo-immunoprecipitation using the patients' sera and cryosections of rat or pig cerebellum combined with mass spectrometrical analysis. Correct identification was ascertained by indirect immunofluorescence and neutralization tests using the target antigens recombinantly expressed in HEK293 cells. Results: Serum and CSF of the index patient produced a fine-granular IgG indirect immunofluorescence staining of the hippocampal and cerebellar molecular layers. Flotillin-1 and flotillin-2 were identified as target autoantigens. They also reacted with recombinant human flotillin-1/2 co-expressed in HEK293 cells, but not with the individual flotillins in fixed-and live-cell assays. Moreover, neutralization using flotillin-1/2, but not the single flotillins, abolished the tissue reactivity of patient serum. Screening of 521 patients, for whom anti-aquaporin-4 testing was requested and negative, revealed 8 additional patients with anti-flotillin-1/2 autoantibodies. All eight were negative for anti-MOG. Six patients ex post fulfilled the revised McDonald criteria for MS. Vice versa, screening of 538 MS sera revealed anti-flotillin-1/2 autoantibodies in eight patients. The autoantibodies were not found in a cohort of 67 patients with other neural autoantibody-associated syndromes and in 444 healthy blood donors. Conclusions: Autoantibodies against the flotillin-1/2 heterocomplex, a peripheral membrane protein that is involved in axon outgrowth and regeneration of the optic nerve, are present in 1-2% of patients with bona fide MS.
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf
اللغة: English
العلاقة: Hahn, S.; Trendelenburg, G.; Scharf, M.; Denno, Y.; Brakopp, S.; Teegen, B.; Probst, C.; Wandinger, K. P.; Buttmann, M.; Haarmann, A.; Szabados, F.; Dahl, M. vom; Kümpfel, T.; Eichhorn, P.; Gold, H.; Paul, F.; Jarius, S.; Melzer, N.; Stöcker, W.; Komorowski, L. (2017): Identification of the flotillin-1/2 heterocomplex as a target of autoantibodies in bona fide multiple sclerosis. In: Journal of Neuroinflammation 14:123 [PDF, 2MB]; https://epub.ub.uni-muenchen.de/52382/1/Hahn_Identification_of_the_flotillin-1_2_heterocomplex_as_a_target_of_autoantibodies_in_bona_fide_multiple_sclerosis.pdfTest; http://nbn-resolving.de/urn:nbn:de:bvb:19-epub-52382-6Test; https://epub.ub.uni-muenchen.de/52382Test/
DOI: 10.1186/s12974-017-0900-z
الإتاحة: https://doi.org/10.1186/s12974-017-0900-zTest
https://epub.ub.uni-muenchen.de/52382/1/Hahn_Identification_of_the_flotillin-1_2_heterocomplex_as_a_target_of_autoantibodies_in_bona_fide_multiple_sclerosis.pdfTest
https://epub.ub.uni-muenchen.de/52382Test/
http://nbn-resolving.de/urn:nbn:de:bvb:19-epub-52382-6Test
رقم الانضمام: edsbas.6CE06996
قاعدة البيانات: BASE